drugset / Trial / NCT07267949
Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Timeline
- Start
- 2025-10-22
- Primary completion
- 2026-11
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AP31969 | Unknown | 100 mg | Oral |
| Subject | AP31969 | Unknown | 200 mg | Oral |
| Subject | AP31969 | Unknown | 350 mg | Oral |
| Subject | AP31969 | Unknown | 500 mg | Oral |